| 5 mins | 30 mins | Hourly | Daily | Weekly |
|---|---|---|---|---|
| BUY | BUY | BUY | SELL | SELL |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MA5 | 4.73▲ | 4.76▲ | 4.76▲ | 4.85▼ | 7.04▼ |
| MA10 | 4.73▲ | 4.76▲ | 4.75▲ | 4.56▲ | 10.76▼ |
| MA20 | 4.73▲ | 4.79▼ | 4.83▼ | 5.16▼ | 9.62▼ |
| MA50 | 4.79▼ | 4.74▲ | 4.61▲ | 10.60▼ | N/A |
| MA100 | 4.82▼ | 4.56▲ | 4.64▲ | 9.41▼ | N/A |
| MA200 | 4.59▲ | 4.69▲ | 8.92▼ | 7.43▼ | N/A |
| 5 mins | 30 mins | Hourly | Daily | Weekly | |
|---|---|---|---|---|---|
| MACD | 0.004▲ | -0.002▼ | -0.019▼ | 0.247▲ | -1.082▼ |
| RSI | 53.221▲ | 50.212▲ | 51.366▲ | 36.305▼ | 42.139▼ |
| STOCH | 44.524 | 70.856 | 57.968 | 63.960 | 26.577 |
| WILL %R | -31.429 | -24.444▲ | -50.725 | -31.200 | -94.108▼ |
| CCI | 51.969 | 7.174 | -43.893 | 30.624 | -108.783▼ |
| ▼ GAP | $NEUP Open Gap Down %2 | Set Alert |
|
Tuesday, November 11, 2025 06:31 AM
Neuphoria Therapeutics (NASDAQ:NEUP) shares gained 4% on Tuesday after the clinical-stage biotechnology firm announced the initiation of a strategic review aimed at maximizing shareholder value. The ...
|
|
Tuesday, November 11, 2025 04:05 AM
Confirms Receipt of Unsolicited Indication of Interest and Director Nominations from Lynx1 Master Fund LPNo Stockholder Action Required at This ...
|
|
Tuesday, November 11, 2025 02:15 AM
Investing.com -- Neuphoria Therapeutics (NASDAQ:NEUP) stock rose 4% after the clinical-stage biotechnology company announced it has initiated a strategic review to maximize stockholder value.
|
| date | open | high | low | close | volume |
|---|---|---|---|---|---|
| 14/11/25 | 4.65 | 4.864 | 4.36 | 4.79 | 332,900 |
| 13/11/25 | 4.87 | 4.87 | 4.61 | 4.75 | 109,400 |
| 12/11/25 | 4.93 | 5.085 | 4.86 | 4.90 | 123,700 |
| 11/11/25 | 5.08 | 5.18 | 4.80 | 4.89 | 519,500 |
| 10/11/25 | 4.15 | 5.1379 | 4.15 | 4.90 | 518,316 |
| 07/11/25 | 4.22 | 4.368 | 4.09 | 4.10 | 332,800 |
| 06/11/25 | 4.50 | 4.50 | 4.2401 | 4.28 | 117,154 |
| 05/11/25 | 4.10 | 4.49 | 3.93 | 4.40 | 474,288 |
| 04/11/25 | 4.25 | 4.41 | 4.15 | 4.22 | 134,500 |
| 03/11/25 | 4.58 | 4.60 | 4.33 | 4.38 | 234,000 |
|
|
||||
|
|
||||
|
|